Mostika LP Benefits & Uses

Mostika LP is used to treat the following -

Other Benefits

Mostika LP Dosage & How to Take

This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.

Find the right dosage based on disease and age

Age Group	Dosage
13 - 18 years (Adolescent)	Disease: Conjunctivitis Before or After Meal: As advised by a physician Single Maximum Dose: 2 drop Dosage Route: Ophthalmic Frequency: 4 daily Course Duration: 7 days Special Instructions: Dosage strength: Loteprednol (0.5% w/v), Moxifloxacin ( 0.5% w/v)
Adult	Disease: Conjunctivitis Before or After Meal: As advised by a physician Single Maximum Dose: 2 drop Dosage Route: Ophthalmic Frequency: 4 daily Course Duration: 7 days Special Instructions: Dosage strength: Loteprednol (0.5% w/v), Moxifloxacin ( 0.5% w/v)
Geriatric	Disease: Conjunctivitis Before or After Meal: As advised by a physician Single Maximum Dose: 2 drop Dosage Route: Ophthalmic Frequency: 4 daily Course Duration: 7 days Special Instructions: Dosage strength: Loteprednol (0.5% w/v), Moxifloxacin ( 0.5% w/v)

Mostika LP Related Warnings

Is the use of Mostika LP safe for pregnant women?

No research has been done to ascertain the safety of Mostika LP in pregnant women. If you are pregnant, it is best to ask a doctor to know if you can take it.

Unknown
Is the use of Mostika LP safe during breastfeeding?

There is no research available on the side effects of Mostika LP in breastfeeding women. Therefore, its impact is unknown.

Unknown
What is the effect of Mostika LP on the Kidneys?

Mostika LP does not damage the kidneys.

Safe
What is the effect of Mostika LP on the Liver?

Mostika LP does not damage the liver.

Safe
What is the effect of Mostika LP on the Heart?

Mostika LP is not harmful for the heart.

Safe

Severe Interaction of Mostika LP with Other Drugs

Mostika LP should not be taken with following medicines due to severe side effects it may cause to patients -

Severe

Disopyramide

Warfarin

Quinidine

Alfuzosin

Amiodarone

Moderate

Bromfenac

Nepafenac

Mild

Iron

Mostika LP Contraindications

If you are suffering from any of the following diseases, you should not take Mostika LP unless your doctor advises you to do so -

Allergy

Frequently asked Questions about Mostika LP

Is this Mostika LP habit forming or addictive?

Mostika LP does not cause addiction.

No
Is it safe to drive or operate heavy machinery when consuming?

After taking Mostika LP you may feel sleepy. So it is not advised to perform these activities.

Dangerous
Is it safe?

Yes, but take Mostika LP only as per medical advice.

Safe, but take only on Doctor's advise
Is it able to treat mental disorders?

Mostika LP is unable to treat or cure mental disorders.

No

Mostika LP Interactions with Food and Alcohol

Interaction between Food and Mostika LP

It is safe to take Mostika LP with food.

Safe
Interaction between Alcohol and Mostika LP

It is difficult to say anything about the effect of Mostika LP and alcohol. No research has been done on this yet.

Unknown

See all substitutes for Mostika LP

Mahaflox LP Eye Drop - ₹170
MFC LT Eye Drop - ₹172
Mlobe LP Eye Drop - ₹169
Moxivail LP Eye Drop - ₹185
Moxigram LX Eye Drop - ₹174
Lotesol M Eye Drop - ₹140
Apdrops LP Eye Drop - ₹160
Lotemox Eye Drop - ₹151
Mflotas LP Eye Drop - ₹141
StayHappi Moxifloxacin Hydrochloride 5 Mg + Lotepretnol 5 Mg Eye Drops - ₹58
4 Quin Lot Eye Drop - ₹152
MOSTIKA LP EYE DROP 5ML - ₹87
Loteprednol + Moxifloxacin Eye Drop - ₹170
Moxluv LT Eye Drop - ₹121
Moxinix LP Eye Drop - ₹130
Moxicon Lp Drop - ₹0
Meflotas LP Eye Drop - ₹129
Vodamox LP Eye Drop - ₹115
Emfozen LP Drops - ₹114

This medicine data has been created by -

Vikas Chauhan

B.Pharma, Pharmacy
5 Years of Experience

References

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lotemax® (loteprednol etabonate)

April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1402

April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 579-584

KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 714

US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Avelox (moxifloxacin hydrochloride)

April Hazard Vallerand, Cynthia A. Sanoski. Davis’s Drug Guide For Nurses. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1402.

Highlights Of Prescribing Information [Internet]: VIGAMOX® (moxifloxacin hydrochloride ophthalmic solution) 0.5% as base Sterile topical ophthalmic solution. USFDA

Product Description [Internet]: LOTEMAX. Bausch & Lomb